We stand at a pivotal moment. AI in pharma and healthcare has transcended the initial hype and is now in a critical phase of adoption and scale. The question is no longer "Does AI work?" but rather, "How do we embed it at scale to transform every facet of healthcare operations?" The potential is immense. However, we also recognize the complexities: ensuring AI models are explainable and trustworthy within a highly regulated environment.

This conference is designed to address these challenges. We will delve into real-world use cases for scaling AI effectively.

Our focus will be structured around three critical pillars:

• Drug Discovery at Scale: We will explore how to move beyond pilot projects to achieve widespread impact and enhance success rates across the drug development pipeline.

• Clinical Trials 2.0: Discover how to make AI-powered clinical trials the standard, optimising efficiency and compliance through AI-driven patient recruitment and trial management.

• Commercial Strategies: We will examine how to scale AI-driven tools that are revolutionising patient engagement and marketing